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Immune function and health outcomes in women
with depression
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Cherie Howk1 and Mary Bennett*2

Abstract
This research reports immune function and health outcomes in women with depression, as compared with a nondepressed control group. Using Psychoneuroimmunolgy theory and a descriptive comparison design, scores on the
Beck Depression Inventory (BDI) were used to divide 40 non-hospitalized Caucasian women between the ages of 18
and 65 years into either the control or depression comparison group. Women with depression were found to report
significantly more incidences of illness over the previous two months and they were found to have significantly more
indicators of illness at the time of the exam as compared to the controls. However, contrary to what has been
documented in some earlier studies of depression, women with depression were not found to have significantly
different immune function measures as compared to the control group. There was also no significant correlation
between scores on the BDI and natural killer cell cytotoxicity in this study. While these findings support a connection
between depression and both increased self-report of illness and increased signs and symptoms of minor illness or
inflammation on physical exam, this study was not able to document that these effects were related to decreased
immune function, as measured by natural killer cell activity or white blood cell counts.
Introduction
Depression is a biological, psychological, and social illness that affects roughly 15 million American adults in
any given year. Depression costs billions of dollars in lost
time, productivity, personnel replacement, medical care
and, tragically, loss of life. The cost to women is disproportionally higher, with women representing about twothirds of those affected [1]. In addition, at least one study
demonstrated that women with depression have higher
costs related to greater work absence than males with
depression [2]. But is all of the morbidity from depression
directly connected to the psychological aspects of the disease, or are people with depression actually more susceptible to physical illnesses?
According to Psychoneuroimmunolgy (PNI) theory, the
central nervous system (CNS), peripheral nervous system
(PNS), endocrine system, and immune system are part of
an intricate communication and feedback system. Any
action that causes change or illness in one part of this system, such as the CNS, can potentially cause changes in
the other parts of the PNI system, such as endocrine or
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immune systems. Evidence suggesting that psychological
stressors such as depression can alter immunological
functions and possibly increase susceptibility to physical
disease has accumulated over the past several decades [3].
Studies of Depression and Immune Function

While there have been several studies indicating that
depression may cause changes in immune function, studies documenting immune changes and actual health outcomes are rare. Therefore, the clinical significance of
immune changes in depression is largely unknown. In
addition, while most studies have found decreased
immune function, particular in severely depressed hospitalized men, this finding has not been consistently supported in studies of non hospitalized women or those
with less severe depression.
One early study of depression and immune function
reported that persons with major depression actually may
have increased numbers of NK cells in the blood, while
other lymphocyte subset counts were not significantly
different from that of control subjects [4]. Another small
study found no differences in a number of immune system parameters using a mixed gender sample. There were
no significant differences in cytokine measures such as
IL-4, IL-10, TNF-alpha, IFN-gamma, no significance dif-

© 2010 Howk and Bennett; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Com-

BioMed Central mons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Howk and Bennett BioPsychoSocial Medicine 2010, 4:3
http://www.bpsmedicine.com/content/4/1/3

ferences in levels of immunoglobulins, and no differences
in the total number of NK cells, B cells, and T cells
between persons with major depression (n = 37) and
healthy control subjects (n = 15) [5]. A third early study
found no significant difference in the number of lymphocytes or lymphocyte subsets between those with depression and those in the control group. There was also no
difference in lymphocyte response to mitogens or NKCA.
However, there were significant differences in subsets of
the sample, with age, severity of depression, and hospitalization states being associated with significant immune
changes. The authors concluded that changes in immune
function may not be found in the overall population of
those with depression, but might be seen in certain subsets, such as those who have more severe depression or
are hospitalized [6].
As time and techniques improved, more studies started
to include a wider range of outcome measures, including
measurement of various inflammatory cytokines. In a
small study of patients with major depression (n = 17), in
addition to decreased NKCA, the patients also had
increased IL-2 levels, compared with the control group (n
= 10) [7]. IL-2 is a cytokine which increases inflammatory
responses and normally increases NKCA, but even with
higher levels of IL-2 the patients in this study still had
lower natural killer cell functioning. Another study of 25
male patients with major depressive disorder documented both decreased NKCA and higher levels of circulating IL-6, another cytokine which increases
inflammation and stimulates immune cell activity [8].
These outcomes indicate that the depressed subjects in
these studies had both decreased cellular immune function (measured by NKCA) and increased inflammatory
cytokines. This later finding could also be of clinical significance if it could be shown that these subjects had
increased signs and symptoms of inflammation, but
health outcomes were not documented in this study.
As can be inferred from the above studies, higher levels
or counts of any given immune system component does
not necessarily indicate better ability to resist disease or
better health outcomes in general. According to a metaanalysis of several studies which measured both cell
counts and the cell's ability to respond to disease causing
organisms, it appears that while an increase in circulating
white cells (usually neutrophils) is sometimes found in
depression, these neutrophils demonstrate decreased
phagocytic activity, indicating a decreased ability to
defend the body against pathogens [9]. Therefore, assays
which measure cellular cytotoxicity (such as measures of
NKCA) may provide a better measure of the immune system's ability to provide an effective defense against disease.
Looking at studies of cellular immune function as measured by cytotoxicity or phagocytic response to mitogens,
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there is now accumulated data that documents generally
decreased NKCA in persons with depression [8-12].
According to a meta-analysis by Irwin and Miller (2007),
depression can lead to decreased cellular immune function as evidenced by decreased NKCA, decreased lymphocyte proliferation in response to mitogens, and
decreased virus specific T cell responses. In addition,
depression can cause increased inflammatory response
from the immune system, as evidenced by increased
overall WBC level and increased levels of pro-inflammatory cytokines [13]. Another important finding is that
alterations in immune function seen in depression can be
improved by successful antidepressant treatment [14-17].
For example, in a study of males with depression, successful treatment of the depression with an SSRI (citalopram)
improved NKCA, while those who demonstrated no clinical response to the antidepressant treatment also had no
improvement in NKCA [18].
Whether the above results hold true in female subjects
is somewhat more debatable. Despite the relatively higher
numbers of women with depression, early studies of
immune function tended to avoid using female subjects,
for fear that hormonal changes would interfere with the
immune function results. A meta-analysis by Zorrilla et
al. noted that studies of depression and immune function
which included higher numbers of female subjects
showed smaller decreases in NK cell functioning [9]. And
a study by Motzer et al. (2002) of women with irritable
bowel syndrome (IBS) and co-morbid depression
reported no significant difference in NKCA between
groups[19].
In summary, the literature to date demonstrates that
most studies of depression and immune function report
lower absolute NK cell counts and/or lower NKCA, particularly in the more seriously depressed and/or hospitalized populations [9]. However, depression related
decreases in NKCA may be gender specific, as studies of
men with depression have more consistently reported
decreased NK activity, compared to studies of women
with depression [9,20]. These findings and others provide
the background and impetus for continued study of
depression, immune function and health outcomes in
women. The hypothesis tested in this study is that
women with depression will have decreased immune
function and increased symptoms of illness and/or
inflammation, compared to women without depression.

Methods
A descriptive comparative design was used to determine
if there was a significant difference between depressed
and non-depressed women on either immune function,
as measured by NKCA and WBC with differentials, or
health outcomes on a physical exam. Methods for this
dissertation study were approved in 2000 by the Indiana
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State University Institutional Review Committee for the
use of Human subjects. Community dwelling (non-hospitalized) women were solicited for inclusion in this study
using a variety of methods, including community bulletin
boards, churches, newspaper advertisements, e-mail,
community mailing, and community clinics. The women
were aware that the researcher was interested in the
effects of depression on women's health, but that they did
not have to be depressed to be included in the study. Participants were pre-screened by phone to determine if
they met the inclusion and exclusionary criteria (see table
1). Those meeting the study criteria were scheduled for
participation. The final sample was made up of 40 nonhospitalized women between the ages of 18 and 65 years
old.
A comparison of demographic variables is displayed in
table 2. The mean age of participants was 41 years old.
Scores on the Beck Depression Inventory (BDI) were
used to divide the participants into either the control or
depression comparison group. Of the forty participants,
23 had BDI scores which indicated at least mild levels of
depression, while 17 had scores which allowed them to be
placed in the control group. The groups did not differ significantly by age, use of antidepressants, menstrual phase
or menstrual day, BMI, number of office visits or use of
antibiotics in the past two months.
Data Collection and Procedures

After informed consent, participants completed the Beck
Depression Inventory, the Health Questionnaire, had a
health history and physical exam, urinalysis, CBC and
blood drawn for the natural killer cell assay. The physical
exams were performed by nurse practitioners who were
blind to subject group, the natural killer cell assay was
performed by a nurse researcher also blind to subject
group. Persons who tested depressed on the BDI were
Table 1: Sample Inclusion and Exclusion Factors
Inclusion Factors

Exclusion Factors

Female

1. Minor surgery in the preceding two weeks

Age 18-65

2. Chronic illness

Non-Pregnant

3. Major surgery in the preceding six months
4. Use of any street drugs or over 1 pack of
cigarettes daily
5. Use of alcohol over 10 ounces per week
6. Taking immunosuppressant.
7. Use of nutritional supplements other than
one daily multivitamin and/or a calcium
supplement
8. Working the 11-7 shift in the past three days
9. Exercising more than seven hours per week
10. Fear of having blood drawn for lab testing
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offered assistance in accessing professional help if they so
desired.
Measures of immunity

Measurement of the total number of circulating leukocytes is a common and easy to conduct test and is frequently used in evaluation of various disease process.
Therefore this test was included as a simple measure of
immune function. A dipstick urine analysis was performed as another test for infection. Both urinalysis and
WBC count were measured by routine laboratory guidelines. The blood was processed in an automated Coulter
counter to determine the WBC count. A CLIA-CERTIFIED laboratory completed the standard WBC and differential.
In addition, a more specific measure of immune function, NCKA, was used to determine if there was significant difference in immune function between depressed
and non-depressed women. For this study, a modified
version of the NK assay was used, which involved K 562
target cells grown up in one culture, then frozen in lots
for use during the entire study. One lot of the prepared
target cells were thawed 72 hours before each assay, then
split 24 hours before use in the assay. In our previous
work a side by side comparison of this modified procedure with the standard procedure yielded a mean testretest reliability of 0.904 for five control subjects over a
five-week period, compared to a mean test-retest reliability of 0.777 for the standard 51 Cr release NK cell activity
assay[21].
NK cell activity was measured using fresh donor cells in
a modified version of the standard four hour chromium
release assay. Triplicate data from the NK assay was
examined to determine measures of central tendency and
check for outliers. The data was accepted or rejected
based on criteria developed by Stone, et al. [22]. The
K562 cells were labeled and viability was ascertained
before data collection procedures each day. If the K562
viability was less than 80% or the spontaneous release was
greater than 10% of the maximum release, another batch
of K562 cells would have been used. For this study the
spontaneous release remained below 10% of the maximum release, and all targets had a viability greater than
80% on all days of the study. Natural killer cell cytotoxicity was determined for effector to target ratios of 40:1,
20:1, 10: and 5:1, which was then was converted into standardized lytic units (LU) using the method described in
previous research [23].
Measures of depression

Due to the ease of administration, the Zung self-rating
depression scale was utilized for telephone prescreening
of participants [24]. Scores on the BDI, which detects and
assess intensity of depression, were used to assign partici-
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Table 2: Comparison of Groups on Demographic Variables
Mean for Depressed
Group (n = 23)

Range for
Depressed Group

Mean for Control
Group
(n = 17)

Range for Control
Group

Sig.

Age

40.56 years old

18-63 years old

43.23 years old

18-65 years old

P = 0.524

BDI Score

24.34

11-51

3.52

0-9

P < = 0.001*

Menstrual Early Fol. Phase

2.13

2.35

P = 0.803

Menstrual Day

Day 7.47

Day 9.05

P = 0.632

Office visits in last 2 months

2 visits

0-30 visits

.411 visits

0-2 visits

P = 0.256

Number of Antibiotic used

.434 Rx

0-3 Rx

.117 Rx

0-1 Rx

P = 0.112

Missed Days work/school

0.652 days

0-3 days

0.058 days

0-1 days

P = 0.007*

pants into either the depression or control group. The
BDI includes an assessment of 21 symptoms and attitudes
that are rated from 0 to 3 in terms of intensity. It takes 5
to 10 minutes to complete and is scored by summing the
ratings of each of the 21 items [25]. The total BDI score
was utilized to determine the level of depression. Participants who scored from 0 to 9 were determined to be
within the normal range and placed in the control group.
Participants who scored between 10 and 18 were classified as mild to moderately depressed; 19 to 29, moderate
to severely depressed; and 30 and above, extremely
severely depressed. All participants that scored above ten
were placed in the depressed group.
Measures of health

The self-report Health and Lifestyle Questionnaire [26]
was used to operationalize a wide variety of self reported
health problems. Test-retest reliability coefficient for this
instrument was reported as 0.89 in prior studies [27]. In
addition to the self-report measure, a physical examination was performed by nurse practitioners to document
signs and symptoms of current illnesses or infectious processes. Examiners were blinded to participant's group status. They followed an established protocol investigating
for generalized infectious and/or inflammatory processes
in the integumentary system, respiratory tract, gastrointestinal tract and genitourinary tract. A routine review of
systems was also completed as part of the physical exam.
Positives and negatives were recorded on the tool provided. Total positives were summed and used as the index
score for physical exams. The higher the score the more
signs and symptoms of illness, infectious and/or inflammatory processes were found.
Statistical Methods

Pearson-r was used to examine relationships among the
variables. A minimum sample size of thirty-two participants insured an 85% chance of detecting a population
Pearson correlation coefficient of 0.5. Therefore, a sample
size of 40 was adequate to provide valuable information

in this initial investigation of depression, immune function and health. Student t-tests were utilized to compare
the two groups on the different variables. However, it
must be noted that the sample size afforded in this study
was too small to obtain power for this analysis.

Results
The hypothesis tested in this study was that women with
depression would have decreased immune function and
increased symptoms of illness and/or inflammation,
compared to women without depression. The second
part of this hypothesis was supported in this study. Student independent t-tests were used to document significant differences between the control and the depression
group. The participants in the depression group were
found to be significantly different than the controls on
several of the health outcomes. Women in the depressed
group had significantly more findings on the review of
systems, physical exam, total physical exam, and number
of days missed from school or work when compared with
women in the comparison group.
Women with depression were found to report significantly more incidences of infection and illness over the
previous two months than the controls (t = -5.05, p < =
0.001). Table 3 shows selected health outcomes for
women in both groups. The mean numbers of illnesses
experienced in the past two months by each group were:
depressed group 188 and control group 53. Additional
findings include significant differences between groups
on the report of headache, upset stomach, nausea and
vomiting, no energy and yeast infections. In each case the
depressed group reported significantly more problems
with these signs and symptoms in the past two months.
In addition, at the time of the physical exam, women with
depression were found to have significantly more positives on the review of systems (t = -4.01, p < = 0.001).
Table 4 demonstrates the findings on the history part of
the physical exam for women in both groups. Depressed
women reported a mean of 8 positives while controls
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reported 3 positives. While the above findings could have
been biased by being primarily self-reported data, women
with depression were also found to have significantly
more indicators of infection and illness at the time of the
physical exam as compared to controls (t = -2.23, p < =
0.032).
Table 4 also demonstrates comparisons on selected
physical exam findings and immune function outcomes
for women in both groups. Nutritional deficit (above
ideal body weight) was the indicator found most often
during the physical exam for subjects in both the
depressed (11) and non-depressed group (9). The next
highest indicator found during the physical exam in the
depressed group was WBCs found in the urine (7), following by yeast (5), sinus tenderness (5), and redness or

exudate in the throat (5). In the non-depressed group, the
second highest finding was redness or exudate in the
throat (7), followed by sinus tenderness (3), redness or
changes in the TM (3), and RBCs found in the urine (3).
Results of the total physical exam (exam positives plus
positives on the review of systems) revealed significant
differences between the groups with depressed women
having more overall positive indicators of infection and
illness (t = -4.18, p < = 0.001). Controls had a mean of 5
positives while depressed women had 11 positives on
exam.
However, the first part of the study hypothesis was not
supported. Women with depression did not have significantly different natural killer cell activity (NKCA) when
compared to the control group (t = -1.78, p = 0.082).

Table 3: Comparison of Incidence of Symptoms over Past Month.
Field

Mean
Depressed
(SD)
(n = 23)

Sum
Depressed

Mean
Control
(SD)
(n = 17)

Sum
Control

Sig.

Headache

24.48
(24.5)

563

9.94
(15.6)

169

P = 0.039*

Acne

4.91
(12.5)

113

.35
(.79)

6

P = 0.097

Upset Stomach

19.09 (23.7)

439

3.88
(5.27)

66

P = 0.007*

Ear Infection

.61
(1.7)

14

.06
(.24)

1

P = 0.151

Sinus Infection

4.83
(12.6)

111

.35
(.70)

6

P = 0.104

Sore Throat

2.00
(4.2)

46

.29
(.69)

5

P = 0.069

Allergies

22.09
(28.5)

508

9.41
(19.5)

160

P = 0.123

Tooth Abscess

.13
(.46)

3

0
(0)

0
(0)

P = 0.186

Nausea/Vomiting

6.65
(13.4)

153

.82
(1.98)

14

P = 0.054

Diarrhea

5.74
(12.5)

132

.76
(1.56)

13

P = 0.073

Muscle Strain

8.913
(17)

205

1.0
(2.12)

17

P = 0.038*

No Energy

39.17
(25.35)

901

6.65
(14.1)

113

P < = .001*

Skin Infections

4.78
(13.2)

110

.12
(.49)

2

P = 0.105

Yeast Infection

.22
(.52)

5

0
(0)

0

P = 0.057

Urinary Tract
Infection

.26
(.45)

6

.06
(.24)

1

P = 0.076

Vaginal Infection

.09
(.29)

2

0
(0)

0

P = 0.162

Howk and Bennett BioPsychoSocial Medicine 2010, 4:3
http://www.bpsmedicine.com/content/4/1/3

Page 6 of 9

Table 4: Comparison of groups on selected physical exam findings
Field

Mean
Depressed
(n = 23)

Sum
Depressed

Mean
Control
(n = 17)

Sum
Control

Sig.

Nutrition

.48

11

.53

9

P = .757

Inflammation

.09

2

.00

0

P = 0.102

Redness

.17

4

.00

0

P = 0.043*

Throat

.22

5

.41

7

P = .194

Sinus

.22

5

.18

3

P = .757

WBC in urine

.30

7

.06

1

P = 0.039*

Nitrites in urine

.09

2

.00

0

P = .162

RBC in urine

.13

3

.18

3

P = .696

Urine clarity

.09

2

.00

0

P = 0.162

Yeast

.22

5

.00

0

P = 0.022*

Mean Depressed

Range

Mean Control

Range

Sig.

29.4

1.9-84

17.01

Range 4.1-52.8

P = 0.082

NCKA (Lytic Units)
WBC (cu mm)

6.56

3.3-9.9

6.14

4.2-7.9

P = 0.371

Symptom Days

188.04

28-378

53.94

0-231

P < 0.001*

Positives on PE

3.13

1-8

1.7

0-4

P = 0.032*

Positives ROS

8.39

1-16

3.58

0-9

P < 0.001*

Total PE Findings

11.52

4-23

5.41

0-13

P = <0.001*

Mean NKCA for those in the depression group was 29.43
lytic units, the control group had a mean NKCA of 17.01
lytic units. In addition, white blood counts were not significantly different between the groups (t = -.91, p =
0.371). In fact, no part of the WBC and differential counts
were found to be significantly different between the
groups.
Table 5 displays correlations examined in this study.
Looking at all the subjects no significant relationships
were found between scores on the BDI and NKCA (r =
.194, p = 0.224), BDI and number of WBC (r = .077, p =
0.637), and BDI and number of objective findings on the
physical exam (r = .194, p = 0.23). There were also no significant correlations between the immune function measures of NKCA or WBC and any of the other main
variables. However, the total physical exam score (objective findings plus review of systems) was significantly correlated with the total self-report of illness (r = .582, p < =
.001). There were also significant correlations found
between scores on the BDI and total self-report of illnesses (r = .792, p < = 0.001), BDI and total physical exam
score (objective findings plus review of systems) (r = .564,
p < = 0.001), and BDI and positive findings on the review
of systems (r = .615, p < = 0.001). Time depressed was
also found to be significantly related to scores on the

review of systems (r-.56, p = .00) and physical exam findings (r = .494, p = .001).

Discussion
Based on PNI theory and the prior work done in this
field, it was hypothesized that women with depression
would have decreased NCKA, and decreased health outcomes on physical exam, compared to a sample of nondepressed women. While there were some significant differences in health outcomes between the two groups,
there were not significant differences in NCKA nor in
WBC counts or differentials, compared to the women in
the control sample.
Depression and NCKA

The results of this study did not support that non-hospitalized women with mild to moderate depression have
decreased NKCA. Earlier research completed primarily
with hospitalized depressed males found significant
depression of the NKCA, while subsequent studies of
non-hospitalized female and mixed gender samples have
not consistently reported decreased NKCA. Meta-analyses of depression and immune have noted that decreased
immune function is more often reported in studies of the
more severely depressed and/or hospitalized depressed
subjects [9,13]. Therefore, inclusion of women who rated
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Table 5: Correlation matrix of variables.
Matrix

NKCA

NKCA

WBC

Self Report

Beck

WBC

Self Report

Beck

Time
depressed

Review
Symptom

Physical Exam

Exam Total

Age

r = .097

r = .162

r = .196

r = .035

r = .119

r = .092

r = .124

r = .039

p = 0.55

p = .319

p = .224

p = 0.83

p = .465

p = 0.57

p = .445

p = .811

r = .127

r = .077

r = .282

r = .257

r = .257

r = .187

r = -.24

p = .436

p = .637

p = .078

p = .536

p = 0.11

p = .249

p = .134

r = .792

r = .497

r = .597

r = .238

r = .582

r = -.17

p = .00*

p = .001*

p = .00*

p = .076

p = .00*

p = .295

r = .608

r = .615

r = .194

r = .564

r = -.15

p = .00*

p = .00*

p = .23

p = .00*

p = .354

r = .56

r = .494

r = .637

r = .068

p = .00*

p = .001*

p = .00*

p = .676

r = .354

r = .934

r = .01

p = .025*

p = .00*

p = .951

r = .66

r = .081

p = .00*

p = .62

Time depressed

Review Symptom

Physical Exam

Exam Total

r = .022
p = .893

as "mild" depression on the BDI or the small sample size
may also have contributed to the non-significant findings
concerning NCKA in this study.
Physical Exam Outcomes

As expected, women with depression were found to selfreport more illness indicators. In addition, they had more
positive physical findings on physical exam than nondepressed participants. The more depressed a person
reported being, the more illness indicators they reported.
The symptoms reported most frequently by the
depressed group were; no energy, headache, allergies,
upset stomach and cough. These are common symptoms
seen by all primary care providers, in that the ten symptoms most commonly presented in primary care by persons with depression include: no energy, headache,
anxiety, depressed mood, backache, insomnia, pains in
the chest, dyspepsia, giddiness, pain in the trunk, arms
and legs [28]. Such symptoms may originate from several
sources. One explanation involves what has been called
the "complainer syndrome" that is, the subjects who com-

plain most about their health may also complain most
about their mood.
In this research, consideration must be given to the
notion that mental factors rather than organic factors
may produce the symptoms reported. Psychological distress may increase care seeking for illness or infections
independent of any effect of actual disease incidence.
However, the positive findings on physical exam noted in
this study were independent of these self-report factors.
Subjects in the depressed group had more physical indications of illness and infection at the time of the exam.
When noting the main physical findings of the depressed
group, WBC's found in the urine, yeast infections and
redness or exudate in the throat, it is difficult to attribute
their physical exam finding to mental factors alone. In
addition, the correlation data in this research found that
the higher women scored on the BDI depression scale,
the more health problems were reported and found on
physical exam. Additionally, the longer a women was
depressed the more physical findings were noted on
exam.
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Lastly, women with depression may have more physical
illness simply because signs and symptoms of physical illness may have been overlooked by health care providers
who were focused on treating the co-morbid diagnosis of
depression. One cannot disregard the barriers that
women with mental illness face when attempting to
obtain sensitive and coordinated health care. It has long
been recognized that primary care providers may routinely fail to diagnose illness and trauma in women with
serious mental illness [29-31]. This often leads to inappropriate or inadequate treatment and increased costs. In
one early study, general medical practitioners missed 32%
of the physical problems and psychiatrists missed 48%.
This same study also found that women had significantly
more undetected medical diagnoses than men [29]. In a
more recent study it was noted that that persons with
mental illness continue to have high levels of undiagnosed or sub-optimally treated co-morbid physical illnesses [32]. The current changes in the health care
delivery and financing systems present special problems
for these women because the emphasis on cost containment can lead to brief interventions that may constitute
less than adequate care.

Conclusion
This research suggests that depression may play a role in
the subsequent development of minor acute infectious
and inflammatory conditions, as measured by outcomes
on a brief physical exam. The mechanism by which
depression influences theses outcomes remains
unknown. This research found that women with depression had more self-report of illness and more physical
evidence of illness and/or inflammatory response on
exam as compared to controls. But the hypothesized
pathway to illness, via alterations of natural killer cell
function or white blood cell function, was not supported
in this particular study. This study does not rule out the
effect of depression on other immune system parameters,
or the effect of depression on health outcomes via behavioral choices. Future research should include a wider variety of both behavioral measures and immune function
outcomes to further delineate the effects of all of these
factors on health outcomes in women with depression.
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